European Surgical Outcomes Study (EuSOS)

September 4, 2012 updated by: Queen Mary University of London

European Surgical Outcomes Study: A Multi-centre, International Seven Day Evaluation of Patient Care and Clinical Outcomes for Patients Undergoing Non-cardiac Surgery

The European Surgical Outcomes Study (EuSOS) is a multi-centre, international cohort study of peri-operative care and clinical outcomes for patients undergoing non-cardiac surgery.

Participating centres throughout Europe will contribute routine clinical data describing all eligible patients who undergo surgery from 4th April 2011 to 11th April 2011. Patients will then be followed until hospital discharge (or for a maximum of 60 days) for duration of hospital stay and hospital mortality. Routine clinical data will also be collected for those patients admitted to critical care at any stage after surgery but during the same hospital admission. Specific objectives are to describe clinical outcomes and standards of peri-operative care for patients undergoing non-cardiac surgery in Europe.

Study Overview

Status

Completed

Conditions

Detailed Description

Research questions

  1. What is the in-hospital mortality rate for patients undergoing non-cardiac surgery in Europe?
  2. What is the duration of hospital stay for patients undergoing non-cardiac surgery in Europe?
  3. What is the current standard of peri-operative critical care provision for patients undergoing non-cardiac surgery in Europe?
  4. What is the current standard of haemodynamic (cardiac output) monitoring for patients undergoing non-cardiac surgery in Europe?
  5. Is there any evidence of differences in the standard of peri-operative care provision for patients undergoing non-cardiac surgery in different health-care systems within Europe?
  6. Is there any evidence of differences in hospital stay and mortality for patients undergoing major non-cardiac surgery in different health-care systems within Europe?
  7. What factors determine planned and unplanned admission to critical care after surgery?
  8. Are the factors associated with critical care admission similar to those associated with post-operative death?

Methods

International cohort study of all adult patients undergoing in-patient non-cardiac surgery from 4th April 2011 to 11th April 2011.

Centres

The investigators aim to recruit as many European centres as possible but anticipate that a minimum of 150 hundred centres in ten or more nations will be required.

Ethics approval

National co-ordinators will be responsible for clarifying the need for ethics approval and applying for this where appropriate. Centres will not be permitted to record data unless ethics approval or an equivalent waiver is in place. This study is in effect a large scale clinical audit. The investigators expect that in most, if not every participating country, there will be no requirement for individual patient consent as all data will be anonymised and is already recorded as part of routine clinical care.

Data collection

Data will be collected describing all eligible patients undergoing surgery within the seven day cohort period. These patients will then be followed up until hospital discharge. Data will then be fully anonymised and transcribed by local investigators onto an internet based electronic CRF. A centre specific form will be completed once for each hospital to provide data including university/non-university hospital, number of operating rooms, number and level of critical care beds, etc.

Data set

An operating room data sheet will be completed once for each patient recruited to include data describing patient factors (age, gender, American Society of Anesthesiologists grade, major co-morbid disease, etc), surgical factors (procedure category, grade and urgency of surgery, grade of surgeon, surgical checklist, etc), anaesthetic factors (anaesthetic technique, haemodynamic monitoring, airway, grade of anaesthetist, etc), post-operative care (post-operative recovery ward stay, post-operative invasive or non-invasive ventilation or inotrope within first 24 hours). A critical care data sheet will be completed once for each patient admitted to critical care at any time after surgery, to include data describing whether admission was planned or unplanned, organ support, SAPS III score and SOFA score etc). Patients will be followed until death or hospital discharge for the following outcomes: duration of critical care stay, critical care mortality, duration of hospital stay and in-hospital mortality.

Sample size calculation

The investigators anticipate that approximately 20,000 patients will be required to provide a sample of up to 2,000 admissions to critical care after surgery. Assuming an overall mortality rate following surgery of 1%, a sample size of 20,000 patients will yield 200 deaths. This will allow the inclusion of at least fifteen variables in a logistic regression model for mortality. The rate of admission to critical care is likely to vary between nations but an overall rate of 10% will yield data describing up to 2000 admissions to critical care, whilst an overall rate of 5% will yield 1000 admissions. This to allow construction of a robust logistic regression model for this outcome. 20,000 patients will also provide >99% confidence for the overall mortality rate with 0.37% confidence width. If 200 deaths are observed in an overall sample of 20,000 patients, the 99% confidence interval for the proportion would be (0.008 - 0.012) with a confidence width of 0.37%. This dataset would also have sufficient generalisability to inform the practice of peri-operative care on an international basis.

Statistical analysis

The data to be collected are all collected as part of routine clinical care. Categorical variables will be described as proportions and will be compared using chi-square or Fisher's exact test. Continuous variable will be described as mean and standard deviation if normally distributed or median and inter-quartile range if not normally distributed. Comparisons of continuous variables will be performed using one-way ANOVA or Mann-Whitney test as appropriate. Univariate analysis will be performed to test factors associated with planned and unplanned admission to critical care and / or in-hospital death. A multiple logistic regression model will be used to identify independent risk factors. A stepwise approach will be used to enter new terms into the logistic regression model where p<0.05 was set as the limit for inclusion of new terms. A logistic regression model will be performed to assess independent association between prognostic factors and outcomes. Results of logistic regression will be reported as adjusted odds ratios (OR) with 95% confidence intervals. A single final analysis is planned at the end of the study.

Organisation

The study will be conducted by the EuSOS study group on behalf of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology. National co-ordinators will lead the project within individual nations and identify participating hospitals, translate study paperwork, distribute study paperwork and ensure necessary regulatory approvals are in place. Local co-ordinators will lead in the EuSOS study in individual institutions ensuring all relevant regulatory approvals are in place and adequate training of staff. They will supervise data collection, ensure timely data return and act as guarantor for the integrity and quality of data collected.

Study Type

Observational

Enrollment (Actual)

46985

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ghent, Belgium
        • National Co-ordinator
      • Zagreb, Croatia
        • National Co-ordinator
      • Nicosia, Cyprus
        • National Co-ordinator
      • Brno, Czech Republic
        • National Co-ordinator
      • Odense, Denmark
        • National Co-ordinator
      • Tallinn, Estonia
        • National Co-ordinator
      • Helsinki, Finland
        • National Co-ordinator
      • Nimes, France
        • National Co-ordinator
      • Berlin, Germany
        • National Co-ordinator
      • Athens, Greece
        • National Co-ordinator
      • Pécs, Hungary
        • National Co-ordinator
      • Reykjavik, Iceland
        • National Co-ordinator
      • Mullingar, Ireland
        • National Co-ordinator
      • Udine, Italy
        • National Co-ordinator
      • Riga, Latvia
        • National Co-ordinator
      • Vilnius, Lithuania
        • National Co-ordinator
      • Leeuwarden, Netherlands
        • National Co-ordinator
      • Bergen, Norway
        • National Co-ordinator
      • Poznan, Poland
        • National Co-ordinator
      • Lisboa, Portugal
        • National Co-ordinator
      • Iaşi, Romania
        • National Co-ordinator
      • Belgrade, Serbia
        • National Co-ordinator
      • Kosice, Slovakia
        • National Co-ordinator
      • Ljubljana, Slovenia
        • National Co-ordinator
      • Valladolid, Spain
        • National Co-ordinator
      • Malmö, Sweden
        • National Co-ordinator
      • Genève, Switzerland
        • National Co-ordinator
      • London, United Kingdom
        • National Co-ordinator

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

In-patient adult non-cardiac surgery

Description

Inclusion Criteria:

  • Consecutive patients admitted to participating centres undergoing elective and non-elective non-cardiac surgery commencing during the seven day cohort period with a planned overnight stay

Exclusion Criteria:

  • patients undergoing planned day-case surgery
  • cardiac surgery
  • neurosurgery
  • radiological procedures
  • obstetric procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
In-patient adult non-cardiac surgery
Consecutive patients admitted to participating centres undergoing elective and non-elective non-cardiac surgery commencing during the seven day study period with a planned overnight stay. All eligible patients undergoing surgery within the seven day study period will be recruited wherever possible.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: In-hospital (maximum 60 days)
Mortality prior to actual hospital discharge regardless of location censored at 60 days.
In-hospital (maximum 60 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of hospital stay
Time Frame: Within single hospital admission
Time in days from day of surgery to actual hospital discharge regardless of location
Within single hospital admission
Planned admission to critical care
Time Frame: Within same hospital admission
Post-operative admission to critical care which was planned and agreed prior to surgery
Within same hospital admission
Unplanned admission to critical care
Time Frame: Within same hospital admission
Unplanned post-operative admission to critical care at any stage in the same hospital admission
Within same hospital admission
Duration of critical care stay
Time Frame: Within same hospital admission
Time in days from admission to critical care to actual discharge from critical care or death
Within same hospital admission
28 day mortality
Time Frame: 28 days
Mortality up to 28 days after primary surgical procedure
28 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Rupert Pearse, MBBS FRCA MD, Queen Mary's University of London, UK
  • Principal Investigator: Andrew Rhodes, MBBS FRCA, St Georges Hospital, London UK
  • Principal Investigator: Rui Moreno, MD, Hospital de Santo António dos Capuchos, Lisboa, Portugal
  • Principal Investigator: Paolo Pelosi, MD, University of Insubria, Varese, Italy.
  • Principal Investigator: Claudia Spies, MD, Charite University, Berlin, Germany
  • Principal Investigator: Jean-Louis Vincent, MD PhD, Erasme Hospital, Free University of Brussels, Belgium.
  • Principal Investigator: Benoit Vallet, MD PhD, Centre Hospitalier Universitaire de Lille, France.
  • Principal Investigator: Philip Metnitz, MD, Medizinische Universität Wien, Austria.
  • Principal Investigator: Peter Bauer, PhD, Medizinische Universität Wien, Austria.
  • Principal Investigator: Andreas Hoeft, MD PhD, University Hospital Bonn, Germany

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

September 15, 2010

First Submitted That Met QC Criteria

September 15, 2010

First Posted (Estimate)

September 16, 2010

Study Record Updates

Last Update Posted (Estimate)

September 5, 2012

Last Update Submitted That Met QC Criteria

September 4, 2012

Last Verified

June 1, 2011

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Non-cardiac Surgery

3
Subscribe